https://old.journalforclinicalstudies.com/asias-clinical-trial-growth-industry-developments-and-challenges/ 2022-11-30T15:17:24+00:00 https://old.journalforclinicalstudies.com/improving-health-literacy-to-transform-clinical-trials/ 2022-11-30T15:15:57+00:00 https://old.journalforclinicalstudies.com/why-do-we-need-patient-diversity-in-clinical-trials/ 2022-11-30T15:15:26+00:00 https://old.journalforclinicalstudies.com/turning-pharmacovigilance-into-a-strategic-advantage/ 2022-11-30T15:14:52+00:00 https://old.journalforclinicalstudies.com/achieving-simultaneous-new-drug-document-submission-for-the-fda-and-ema/ 2022-11-30T15:14:20+00:00 https://old.journalforclinicalstudies.com/how-to-streamline-a-complex-process-the-value-add-of-experienced-medical-writers-for-oncology-dossiers/ 2022-11-30T15:13:45+00:00 https://old.journalforclinicalstudies.com/how-the-fda-sped-up-cancer-product-development-and-reviews-during-a-global-pandemic/ 2022-11-30T15:12:57+00:00 https://old.journalforclinicalstudies.com/kyowa-kirin-offloads-mature-drugs-to-grunenthal-amid-challenging-business-environment/ 2022-11-29T14:14:30+00:00 https://old.journalforclinicalstudies.com/bayers-blockbuster-hopeful-nubeqa-debuts-in-later-stage-prostate-cancer-in-uk-under-early-access-program/ 2022-11-29T14:12:13+00:00 https://old.journalforclinicalstudies.com/spying-new-horizons-xeris-starts-work-on-subcutaneous-version-of-rare-disease-drug/ 2022-11-29T14:10:36+00:00 https://old.journalforclinicalstudies.com/genentech-starts-phase-2-trial-to-optimize-delivery-of-eye-disease-cell-therapy/ 2022-11-29T13:54:42+00:00 https://old.journalforclinicalstudies.com/on-a-roll-takedas-dengue-vaccine-shifts-into-fdas-fast-review-lane/ 2022-11-24T09:26:19+00:00 https://old.journalforclinicalstudies.com/jjs-nasal-spray-spravato-bests-former-az-drug-seroquel-xr-in-treatment-resistant-depression-trial/ 2022-11-24T09:23:43+00:00 https://old.journalforclinicalstudies.com/teva-abbvies-allergan-lock-in-6-6b-deal-to-settle-thousands-of-us-opioid-lawsuits/ 2022-11-24T09:22:20+00:00 https://old.journalforclinicalstudies.com/julia-forjanic-klapproth-senior-partner-at-trilogy-writing-consulting-receives-the-harold-swanberg-distinguished-service-award-2022/ 2022-11-23T14:08:30+00:00 https://old.journalforclinicalstudies.com/novartis-targets-eye-respiratory-units-for-potential-sell-offs-after-sandoz-bloomberg/ 2022-11-17T09:37:19+00:00 https://old.journalforclinicalstudies.com/kindeva-links-up-with-former-pfizer-unit-meridian-to-form-drug-device-cdmo-specialist/ 2022-11-17T09:35:26+00:00 https://old.journalforclinicalstudies.com/another-day-another-fda-reprimand-for-troubled-indian-manufacturer-lupin/ 2022-11-17T09:33:15+00:00 https://old.journalforclinicalstudies.com/cphi-frankfurt-2022-global-pharma-confidence-hits-record-high-in-the-annual-cphi-pharma-index/ 2022-11-11T12:00:24+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2022/11/Screenshot-2022-11-11-at-11.50.28.png https://old.journalforclinicalstudies.com/wp-content/uploads/2022/11/2.png https://old.journalforclinicalstudies.com/wp-content/uploads/2022/11/3.png https://old.journalforclinicalstudies.com/cphi-excellence-in-pharma-award-winners-2022/ 2022-11-11T11:56:40+00:00 https://old.journalforclinicalstudies.com/astellas-offers-a-hot-take-on-menopause-symptoms-knowledge/ 2022-11-09T15:24:32+00:00 https://old.journalforclinicalstudies.com/nice-signs-off-on-mercks-keytruda-for-early-stage-triple-negative-breast-cancer/ 2022-11-09T15:23:24+00:00 https://old.journalforclinicalstudies.com/modernas-spikevax-carries-higher-risk-of-myocarditis-than-pfizers-comirnaty-study-says/ 2022-11-09T15:21:00+00:00 https://old.journalforclinicalstudies.com/regenerons-libtayo-finally-scores-keytruda-matching-fda-nod-in-newly-diagnosed-lung-cancer-can-it-catch-up/ 2022-11-09T15:19:48+00:00 https://old.journalforclinicalstudies.com/boehringer-taps-former-novartis-leader-to-fill-chief-medical-officer-position/ 2022-11-09T15:18:04+00:00 https://old.journalforclinicalstudies.com/vaccine-maker-medicago-plots-62-layoffs-in-north-carolina-by-year-end/ 2022-11-02T09:32:40+00:00 https://old.journalforclinicalstudies.com/pfizer-boosts-covid-vaccine-projection-to-34b-on-the-back-of-strong-comirnaty-haul/ 2022-11-02T09:24:55+00:00 https://old.journalforclinicalstudies.com/despite-recent-progress-incyte-still-far-off-from-pricing-goal-for-key-eczema-launch-opzelura/ 2022-11-02T09:23:51+00:00 https://old.journalforclinicalstudies.com/eli-lilly-walks-diabetes-tightrope-as-novo-nordisk-shortages-drive-demand-for-trulicity-and-mounjaro/ 2022-11-02T09:22:29+00:00 https://old.journalforclinicalstudies.com/lilly-pumps-50m-into-purdue-pact-to-study-intrathecal-and-nanoparticle-drug-delivery/ 2022-11-02T09:21:12+00:00 https://old.journalforclinicalstudies.com/fda-keeps-jazzs-lung-cancer-accelerated-approval-in-place-for-now-despite-failed-trial-and-calls-for-withdrawal/ 2022-10-27T08:25:45+00:00 https://old.journalforclinicalstudies.com/aiming-to-block-entresto-generics-novartis-sues-mylan-alembic-and-others-for-patent-infringement/ 2022-10-27T08:23:00+00:00 https://old.journalforclinicalstudies.com/sanofi-harnesses-dassaults-digital-twin-tech-to-optimize-production-at-future-vaccine-plants/ 2022-10-27T08:21:40+00:00 https://old.journalforclinicalstudies.com/otc-birth-control-pill-delayed-as-fda-postpones-expert-meeting-for-perrigo-drug/ 2022-10-27T08:19:41+00:00 https://old.journalforclinicalstudies.com/gsks-oral-anemia-drug-bruised-with-fda-panel-partial-snub-in-chronic-kidney-disease/ 2022-10-27T08:17:45+00:00 https://old.journalforclinicalstudies.com/pci-pharma-services/ 2022-10-24T10:38:51+00:00 https://old.journalforclinicalstudies.com/astrazenecas-evusheld-loses-potency-against-new-omicron-subvariant-fda-warns/ 2022-10-20T14:16:28+00:00 https://old.journalforclinicalstudies.com/in-daiichi-case-court-upholds-jurys-177-8m-infringement-ruling-against-novartis/ 2022-10-20T14:15:29+00:00 https://old.journalforclinicalstudies.com/after-years-of-manufacturing-woes-takeda-is-calling-it-quits-on-natpara/ 2022-10-17T15:01:22+00:00 https://old.journalforclinicalstudies.com/constipation-prescription-awareness-remains-low-despite-known-risks-of-long-term-otc-meds-report/ 2022-10-17T14:59:09+00:00 https://old.journalforclinicalstudies.com/roche-touts-evrysdi-win-in-previously-treated-sma-patients-turning-up-heat-in-rivalry-with-biogen-and-novartis/ 2022-10-17T14:54:37+00:00 https://old.journalforclinicalstudies.com/beigene-heaps-more-pressure-on-abbvie-jj-with-new-brukinsa-head-to-head-win-over-imbruvica/ 2022-10-17T14:52:51+00:00 https://old.journalforclinicalstudies.com/ionis-a-frequent-big-pharma-partner-plots-new-manufacturing-site-to-support-pipeline/ 2022-10-17T14:48:43+00:00 https://old.journalforclinicalstudies.com/what-passive-packaging-options-are-available-when-shipping-clinical-trials-at-frozen-temperatures/ 2022-10-04T09:07:56+00:00 https://old.journalforclinicalstudies.com/delivering-on-the-promise-of-digital-trials-simplified-experiences-for-sites-and-patients/ 2022-10-04T09:07:22+00:00 https://old.journalforclinicalstudies.com/powerful-techniques-promoting-gene-therapy-and-gene-mediated-cell-therapy-progress/ 2022-10-04T09:06:47+00:00 https://old.journalforclinicalstudies.com/clinical-trial-feasibility-in-a-changing-world-current-trends-and-prospects/ 2022-10-04T09:06:18+00:00 https://old.journalforclinicalstudies.com/longitudinal-qualitative-research-capturing-the-patient-voice-enhancing-patient-centricity/ 2022-10-04T09:05:47+00:00 https://old.journalforclinicalstudies.com/understanding-how-intellectual-property-insurance-can-protect-your-business/ 2022-10-04T09:05:16+00:00 https://old.journalforclinicalstudies.com/bridging-the-gaps-in-the-analytical-procedure-with-bayesian-statistics/ 2022-10-04T09:04:41+00:00 https://old.journalforclinicalstudies.com/early-adoption-of-an-integrated-product-development-strategy-will-reap-dividends/ 2022-10-04T09:03:59+00:00 https://old.journalforclinicalstudies.com/an-open-letter-of-appreciation-to-clincial-trial-participants-patient-advisors-caregivers-and-healthcare-professionals/ 2022-10-04T09:03:31+00:00 https://old.journalforclinicalstudies.com/the-importance-of-conducting-diverse-us-trials-for-us-cancer-patients/ 2022-10-04T09:03:03+00:00 https://old.journalforclinicalstudies.com/talking-point-with-pci-pharma-services/ 2022-10-04T09:02:32+00:00 https://old.journalforclinicalstudies.com/merck-inks-deal-with-sinopharm-to-commercialize-covid-19-pills-in-china/ 2022-09-29T08:29:58+00:00 https://old.journalforclinicalstudies.com/sanofi-expects-major-boost-from-foreign-currency-fluctuations-in-third-quarter/ 2022-09-29T08:21:21+00:00 https://old.journalforclinicalstudies.com/eli-lilly-hit-with-another-age-discrimination-lawsuit-this-time-from-a-federal-agency/ 2022-09-29T08:20:04+00:00 https://old.journalforclinicalstudies.com/novo-nordisk-gilead-bms-and-astrazeneca-will-feel-the-most-pain-from-bidens-pricing-bill-analysts/ 2022-09-29T08:18:41+00:00 https://old.journalforclinicalstudies.com/johnson-johnson-defends-bankruptcy-play-in-appeals-court-but-plaintiffs-call-it-a-bad-faith-move/ 2022-09-21T13:36:24+00:00 https://old.journalforclinicalstudies.com/seagens-tukysa-picks-up-fda-priority-review-after-merck-buyout-talks-said-to-sputter/ 2022-09-21T13:35:22+00:00 https://old.journalforclinicalstudies.com/spectrum-oncopeptides-oncology-drugs-have-much-to-overcome-heading-into-fda-adcomm/ 2022-09-21T13:33:51+00:00 https://old.journalforclinicalstudies.com/biontechs-covid-vaccine-sales-are-poised-to-slip-but-the-shot-will-remain-a-cash-cow-in-the-long-term-analysts/ 2022-09-21T13:32:32+00:00 https://old.journalforclinicalstudies.com/teva-ceo-schultz-likely-wont-renew-employment-contract-next-year-reports/ 2022-09-21T13:31:28+00:00 https://old.journalforclinicalstudies.com/hemophilia-gene-therapies-from-biomarin-csl-pick-up-an-early-icer-endorsement/ 2022-09-15T08:14:26+00:00 https://old.journalforclinicalstudies.com/under-bidens-us-biomanufacturing-order-hhs-and-dod-earmark-1b-for-domestic-production-boost/ 2022-09-15T08:13:04+00:00 https://old.journalforclinicalstudies.com/south-africas-biovac-produces-first-pfizer-covid-19-vaccine-doses-report/ 2022-09-15T08:11:29+00:00 https://old.journalforclinicalstudies.com/take-2-hanmi-relaunches-liver-drug-after-boosting-bioavailabilityv/ 2022-09-15T08:09:48+00:00 https://old.journalforclinicalstudies.com/trilogy-writing-consulting-gains-pif-tick-accreditation-to-be-recognised-as-a-trusted-information-creator/ 2022-09-04T18:37:24+00:00 https://old.journalforclinicalstudies.com/bayers-bluerock-inks-cardiovascular-cell-therapy-delivery-deal/ 2022-08-31T12:35:24+00:00 https://old.journalforclinicalstudies.com/amid-launch-efforts-neurocrine-doles-out-48m-to-acquire-small-uk-biotech-diurnal/ 2022-08-31T12:34:10+00:00 https://old.journalforclinicalstudies.com/astrazeneca-ceo-soriot-questions-value-of-annual-covid-boosters-in-healthy-people/ 2022-08-31T12:29:37+00:00 https://old.journalforclinicalstudies.com/gates-foundation-bankrolls-development-of-refillable-long-acting-contraceptive-implant/ 2022-08-31T12:26:37+00:00 https://old.journalforclinicalstudies.com/novartis-hit-with-entresto-patent-suit-from-universities-amid-legal-fight-with-generics-makers/ 2022-08-31T12:25:22+00:00 https://old.journalforclinicalstudies.com/novartis-cuts-manufacturing-jobs-closes-north-carolina-plant-ahead-of-sandoz-spinoff/ 2022-08-31T12:22:22+00:00 https://old.journalforclinicalstudies.com/checkpoint-to-wind-down-and-close-cancer-trial-due-to-russia-ukraine-war/ 2022-08-25T08:39:17+00:00 https://old.journalforclinicalstudies.com/roche-enters-prostate-cancer-deal-with-china-based-jemincare/ 2022-08-25T08:34:18+00:00 https://old.journalforclinicalstudies.com/aeglea-bio-announces-layoffs-ceo-departure/ 2022-08-25T08:31:27+00:00 https://old.journalforclinicalstudies.com/johnson-johnson-lost-to-pfizer-in-bidding-war-for-global-blood-therapeutics-bloomberg/ 2022-08-25T08:27:06+00:00 https://old.journalforclinicalstudies.com/bavarian-nordic-ramps-up-monkeypox-vaccine-manufacturing-capacity-reopens-bulk-facility/ 2022-08-25T08:20:22+00:00 https://old.journalforclinicalstudies.com/how-to-hire-a-translation-agency/ 2022-08-12T08:53:54+00:00 https://old.journalforclinicalstudies.com/the-surge-of-digital-health-technologies-modernising-clinical-research/ 2022-08-12T08:53:27+00:00 https://old.journalforclinicalstudies.com/transcriptome-analysis-of-acute-myeloid-leukaemia-cells/ 2022-08-12T08:52:54+00:00 https://old.journalforclinicalstudies.com/challenges-of-drug-development-in-drug-resistant-focal-epilepsy/ 2022-08-12T08:52:25+00:00 https://old.journalforclinicalstudies.com/regenerative-medicine-confusion-or-complacency/ 2022-08-12T08:51:57+00:00 https://old.journalforclinicalstudies.com/the-relevance-of-the-guidelines-on-good-distribution-practice-gdp-in-the-world-of-international-clinical-trials/ 2022-08-12T08:51:28+00:00 https://old.journalforclinicalstudies.com/get-your-ducks-in-a-row-for-the-data-driven-future/ 2022-08-12T08:50:59+00:00 https://old.journalforclinicalstudies.com/calculating-sample-size-for-medical-device-studies/ 2022-08-12T08:50:26+00:00 https://old.journalforclinicalstudies.com/international-clinical-trials-day-rd-experts-weigh-in-on-what-the-future-holds/ 2022-08-12T08:49:56+00:00 https://old.journalforclinicalstudies.com/rapid-rise-of-decentralised-clinical-trials/ 2022-08-12T08:49:26+00:00 https://old.journalforclinicalstudies.com/broadening-the-treatment-horizon-for-heart-failure-patients/ 2022-08-12T08:48:57+00:00 https://old.journalforclinicalstudies.com/an-alternative-approach-to-continued-covid-19-research/ 2022-08-12T08:48:26+00:00 https://old.journalforclinicalstudies.com/novartis-new-rare-disease-drug-vijoice-named-as-an-empty-vessel-poised-to-be-filled/ 2022-08-11T07:58:02+00:00 https://old.journalforclinicalstudies.com/gsk-iqvia-team-up-on-vaccine-track-to-spotlight-shot-trends-across-the-us/ 2022-08-11T07:57:01+00:00 https://old.journalforclinicalstudies.com/new-ceo-maselli-extends-catalents-expansion-blitz-with-475m-buyout-of-cdmo-metrics/ 2022-08-11T07:55:54+00:00 https://old.journalforclinicalstudies.com/amid-wegovys-supply-woes-novo-nordisk-sees-surging-demand-for-its-original-obesity-drug-saxenda/ 2022-08-04T08:41:31+00:00 https://old.journalforclinicalstudies.com/amid-covid-vaccine-demand-slump-moderna-recorded-800m-plus-in-charges-for-unused-inventory-manufacturing-capacity-and-more/ 2022-08-04T08:39:58+00:00 https://old.journalforclinicalstudies.com/after-forking-over-900m-for-libtayo-rights-regeneron-expects-slight-delay-for-lung-cancer-combo/ 2022-08-04T08:38:20+00:00 https://old.journalforclinicalstudies.com/mercks-keytruda-on-a-losing-streak-fails-in-once-fda-rejected-liver-cancer-use-and-prostate-cancer-again/ 2022-08-04T08:36:43+00:00 https://old.journalforclinicalstudies.com/in-gsk-trade-secrets-case-appeals-court-backs-short-sentences-against-prosecutors-wishes/ 2022-08-04T08:35:20+00:00 https://old.journalforclinicalstudies.com/lilly-az-abbvie-and-jj-face-big-potential-hit-from-medicare-pricing-bill-analysts/ 2022-08-04T08:34:13+00:00 https://old.journalforclinicalstudies.com/fda-puts-the-microscope-on-2-more-cancer-approvals-without-voluntary-withdrawals/ 2022-07-24T13:55:51+00:00 https://old.journalforclinicalstudies.com/roche-hails-excellent-uptake-of-eylea-rival-vabysmo-as-it-lauds-consumers-switching-from-its-competitor/ 2022-07-24T13:54:32+00:00 https://old.journalforclinicalstudies.com/new-eli-lilly-roche-meds-win-backing-from-eu-committee-but-clovis-rubraca-nixed-in-late-stage-ovarian-cancer/ 2022-07-24T13:53:27+00:00 https://old.journalforclinicalstudies.com/after-failed-alzheimers-launch-biogen-writes-off-the-remaining-value-of-its-aduhelm-inventory/ 2022-07-24T13:50:20+00:00 https://old.journalforclinicalstudies.com/tower-cold-chain/ 2022-07-22T13:10:40+00:00 https://old.journalforclinicalstudies.com/novartis-shelves-a-pd-1-bid-in-non-small-cell-lung-cancer-after-fda-feedback/ 2022-07-20T15:28:29+00:00 https://old.journalforclinicalstudies.com/mercks-keytruda-posts-rare-flop-in-head-and-neck-cancer-trial/ 2022-07-20T15:27:10+00:00 https://old.journalforclinicalstudies.com/daiichi-sankyo-willfully-infringed-seagen-patent-in-creating-enhertu-court-rules/ 2022-07-20T15:25:54+00:00 https://old.journalforclinicalstudies.com/an-abundance-of-car-ts-37b-cell-therapy-cancer-market-cant-support-congested-pipeline-report-says/ 2022-07-20T15:21:36+00:00 https://old.journalforclinicalstudies.com/incytes-topical-jak-opzelura-nabs-landmark-vitiligo-nod-after-brief-delay-this-spring/ 2022-07-20T15:16:04+00:00 https://old.journalforclinicalstudies.com/novo-nordisk-eli-lilly-poised-to-divvy-up-obesity-market-that-could-be-worth-50b-in-2030-analysts/ 2022-07-20T15:14:51+00:00 https://old.journalforclinicalstudies.com/teva-shells-out-24-8m-plus-20m-in-narcan-to-settle-opioid-litigation-in-san-francisco/ 2022-07-14T08:02:00+00:00 https://old.journalforclinicalstudies.com/astrazeneca-pfizer-novartis-and-more-lose-out-in-chinas-latest-round-of-drug-price-cuts/ 2022-07-14T08:00:26+00:00 https://old.journalforclinicalstudies.com/curevacs-patent-infringement-case-against-biontech-has-500m-of-potential-upside-analyst/ 2022-07-14T07:54:13+00:00 https://old.journalforclinicalstudies.com/athenex-unloads-stake-in-chinese-api-production-business-for-19m-to-bolster-its-financials/ 2022-07-14T07:52:59+00:00 https://old.journalforclinicalstudies.com/after-building-new-plant-and-signing-on-with-abbvie-regenxbio-enters-commercial-phase/ 2022-07-14T07:51:43+00:00 https://old.journalforclinicalstudies.com/astrazeneca-gsk-and-more-weathered-q2s-economic-headwinds-but-roches-stock-took-a-hit-analysts/ 2022-07-07T09:04:38+00:00 https://old.journalforclinicalstudies.com/pfizer-gets-access-to-touchlights-doggybone-dna-tech-to-make-vaccines-gene-therapies-and-more/ 2022-07-07T09:03:32+00:00 https://old.journalforclinicalstudies.com/roches-lunsumio-eyes-year-end-fda-verdict-to-be-first-bispecific-for-non-hodgkin-lymphoma/ 2022-07-07T09:02:37+00:00 https://old.journalforclinicalstudies.com/viatris-starts-yet-another-insulin-biosimilar-recall-over-potential-missing-labels/ 2022-07-07T09:01:29+00:00 https://old.journalforclinicalstudies.com/roche-pfizer-and-viiv-top-patient-groups-views-of-leading-pharmas-for-esg-work-report/ 2022-07-07T08:59:57+00:00 https://old.journalforclinicalstudies.com/us-secures-more-lilly-covid-19-antibodies-for-275m-but-with-pandemic-funding-uncertain-this-may-be-a-swan-song/ 2022-06-30T08:27:54+00:00 https://old.journalforclinicalstudies.com/gilead-sanofi-gsk-and-more-to-pay-for-employees-abortion-related-travel-costs-after-roe-ruling/ 2022-06-30T08:26:25+00:00 https://old.journalforclinicalstudies.com/with-congress-weighing-insulin-cost-cap-sanofi-slashes-price-for-uninsured-in-us/ 2022-06-30T08:25:06+00:00 https://old.journalforclinicalstudies.com/johnson-johnson-refreshes-positively-fearless-hiv-campaign-with-a-new-digital-presence-and-lgbtq-ambassador/ 2022-06-30T08:24:16+00:00 https://old.journalforclinicalstudies.com/fujifilm-plots-1-6b-expansion-at-cdmo-sites-in-denmark-and-texas-adding-450-jobs/ 2022-06-30T08:23:03+00:00 https://old.journalforclinicalstudies.com/leaner-and-simpler-novartis-details-plans-to-cut-8000-jobs-worldwide/ 2022-06-30T08:21:59+00:00 https://old.journalforclinicalstudies.com/eli-lilly-finds-stigma-is-one-of-the-worst-parts-of-migraine-as-it-aims-to-help-break-the-taboo/ 2022-06-22T13:33:14+00:00 https://old.journalforclinicalstudies.com/game-on-pfizer-mercks-vaxneuvance-boosts-pneumococcal-vaccine-fight-with-coveted-pediatric-nod/ 2022-06-22T13:27:52+00:00 https://old.journalforclinicalstudies.com/florida-man-arrested-in-scheme-to-sell-230m-in-adulterated-hiv-meds-to-unsuspecting-patients/ 2022-06-22T13:26:54+00:00 https://old.journalforclinicalstudies.com/bms-pfizer-and-merck-face-steep-patent-cliffs-but-all-have-the-financial-flexibility-for-ma-moodys/ 2022-06-22T13:26:09+00:00 https://old.journalforclinicalstudies.com/gsk-opens-doors-at-110m-biologics-smart-factory-in-uk/ 2022-06-22T13:24:52+00:00 https://old.journalforclinicalstudies.com/astrazeneca-to-build-production-facility-in-china-for-copd-inhaler-breztri/ 2022-06-22T13:23:53+00:00 https://old.journalforclinicalstudies.com/artificial-intelligence-in-clinical-medical-research/ 2022-06-21T12:53:02+00:00 https://old.journalforclinicalstudies.com/blinding-and-therapeutic-setting-key-to-success/ 2022-06-21T12:52:19+00:00 https://old.journalforclinicalstudies.com/personalised-medicine-and-clinical-studies-the-attempt-to-untie-a-gordian-knot/ 2022-06-21T12:51:19+00:00 https://old.journalforclinicalstudies.com/growing-the-pool-of-clinical-research-investigators-in-malaysia/ 2022-06-21T12:50:44+00:00 https://old.journalforclinicalstudies.com/why-risk-based-quality-management-represents-the-future-of-clinical-research/ 2022-06-21T12:49:41+00:00 https://old.journalforclinicalstudies.com/overcoming-the-challenges-of-obtaining-informed-consent-during-the-pandemic/ 2022-06-21T12:49:12+00:00 https://old.journalforclinicalstudies.com/six-ways-the-shift-to-digital-will-redefine-product-development-in-2022/ 2022-06-21T12:48:44+00:00 https://old.journalforclinicalstudies.com/accelerating-the-transformation-of-healthcare-through-open-source-algorithms/ 2022-06-21T12:48:16+00:00 https://old.journalforclinicalstudies.com/a-long-but-worthwhile-wait-for-vitiligo-treatments/ 2022-06-21T12:47:47+00:00 https://old.journalforclinicalstudies.com/achieving-diversity-and-inclusion-in-covid-19-vaccination-trials/ 2022-06-21T12:47:19+00:00 https://old.journalforclinicalstudies.com/covis-controversial-makena-gets-fda-hearing-date-in-bid-to-stay-on-the-market/ 2022-06-16T08:24:59+00:00 https://old.journalforclinicalstudies.com/fda-staff-reveal-flaws-with-acadias-2nd-nuplazid-try-in-alzheimers-psychosis/ 2022-06-16T08:23:39+00:00 https://old.journalforclinicalstudies.com/modernas-covid-vaccine-wins-unanimous-fda-panel-backing-for-kids-6-to-17/ 2022-06-16T08:22:29+00:00 https://old.journalforclinicalstudies.com/pfizer-runs-first-cibinqo-eczema-tv-ad-as-it-forgoes-actors-and-leans-heavily-on-a-blue-hue/ 2022-06-16T08:19:09+00:00 https://old.journalforclinicalstudies.com/genentechs-spinal-muscular-atrophy-song-played-at-special-olympics-florida-closing-ceremony/ 2022-06-16T08:17:39+00:00 https://old.journalforclinicalstudies.com/eli-lillys-olumiant-snags-biopharmas-first-fda-green-light-for-alopecia-areata/ 2022-06-16T08:14:56+00:00 https://old.journalforclinicalstudies.com/kyowa-kirin-goes-for-the-glow-to-bring-awareness-to-rare-bone-disease-xlh/ 2022-06-09T13:53:18+00:00 https://old.journalforclinicalstudies.com/fraudster-in-gileads-counterfeiting-case-gets-prison-sentence-in-a-separate-suit-with-an-unnamed-pharma-for-7-2m-in-bogus-reimbursement-claims/ 2022-06-09T13:50:47+00:00 https://old.journalforclinicalstudies.com/pharmather-fleshes-out-ketamine-delivery-portfolio-with-deal-for-on-body-injector/ 2022-06-09T13:46:00+00:00 https://old.journalforclinicalstudies.com/gsks-viiv-to-work-with-medicines-patent-pool-generic-manufacturers-to-bolster-access-to-long-acting-hiv-prevention-med-apretude/ 2022-06-09T13:40:29+00:00 https://old.journalforclinicalstudies.com/almirall-ramping-up-its-klisyri-launch-wants-patients-to-listen-to-what-your-marks-whisper-to-you/ 2022-06-09T13:38:07+00:00 https://old.journalforclinicalstudies.com/pfizer-and-moderna-rapidly-falling-out-of-favor-as-americans-favorite-brands-report/ 2022-05-31T09:42:17+00:00 https://old.journalforclinicalstudies.com/sk-advances-gates-backed-covid-19-antiviral-spray-toward-clinic/ 2022-05-31T09:01:26+00:00 https://old.journalforclinicalstudies.com/novavax-fashionably-late-to-the-covid-19-vaccine-party-could-still-reap-5b-in-2022-analyst/ 2022-05-31T09:00:21+00:00 https://old.journalforclinicalstudies.com/for-incytes-eczema-cream-opzelura-consumer-complaint-reveals-ongoing-quality-woes-replacement-backlog/ 2022-05-31T08:56:49+00:00 https://old.journalforclinicalstudies.com/pfizers-covid-pill-paxlovid-gets-boost-in-britain-thanks-to-spot-in-national-trial/ 2022-05-31T08:56:05+00:00 https://old.journalforclinicalstudies.com/novartis-aims-to-keep-canakinumabs-early-lung-cancer-hopes-alive-despite-metastatic-failure/ 2022-05-31T08:55:27+00:00 https://old.journalforclinicalstudies.com/moderna-cfo-meline-steps-down-42-million-richer-passing-reins-to-incoming-finance-chief-gomez/ 2022-05-26T14:20:47+00:00 https://old.journalforclinicalstudies.com/myovant-pfizers-expansion-bid-for-myfembree-hits-a-snag-at-the-fda/ 2022-05-26T14:19:23+00:00 https://old.journalforclinicalstudies.com/eli-lilly-plots-2-1b-manufacturing-expansion-at-americas-crossroads-with-500-new-hires/ 2022-05-26T08:24:04+00:00 https://old.journalforclinicalstudies.com/teva-abbvies-allergan-hand-over-161m-to-settle-opioid-lawsuit-in-west-virginia/ 2022-05-26T08:22:49+00:00 https://old.journalforclinicalstudies.com/ptsd-treatment-startups-billboards-speak-to-healthcare-workers-first-responders-your-trauma-is-valid/ 2022-05-26T08:21:45+00:00 https://old.journalforclinicalstudies.com/pharma-bucks-trend-shunning-digital-and-sticking-with-tv-when-it-comes-to-ads/ 2022-05-26T08:20:26+00:00 https://old.journalforclinicalstudies.com/sk-life-science-kicks-xcopri-sales-into-high-gear-with-new-campaign/ 2022-05-26T08:19:22+00:00 https://old.journalforclinicalstudies.com/moderna-ceo-stephane-bancel-for-helping-slay-covid-knighted-in-france/ 2022-05-26T08:18:16+00:00 https://old.journalforclinicalstudies.com/ready-to-go-to-fda-can-hengruis-china-made-pd-1-liver-cancer-immunotherapy-change-the-tides/ 2022-05-16T10:08:12+00:00 https://old.journalforclinicalstudies.com/lillys-highly-anticipated-diabetes-drug-mounjaro-wins-fda-blessing/ 2022-05-16T10:05:31+00:00 https://old.journalforclinicalstudies.com/trial-for-controversial-china-made-alzheimers-drug-aborted-as-capital-raise-hits-snag-covid-hurts-sales/ 2022-05-16T10:04:20+00:00 https://old.journalforclinicalstudies.com/amgen-finds-a-dance-partner-in-lance-bass-urging-psoriatic-arthritis-patients-to-do-a-double-take-on-the-disease/ 2022-05-16T10:02:04+00:00 https://old.journalforclinicalstudies.com/aurobindo-pharma-slapped-with-form-483-as-fda-inspectors-cite-6-findings/ 2022-05-16T10:00:22+00:00 https://old.journalforclinicalstudies.com/novartis-sandoz-strikes-at-roche-with-first-us-generic-of-blockbuster-esbriet/ 2022-05-16T09:59:13+00:00 https://old.journalforclinicalstudies.com/modernas-new-cfo-out-the-door-one-month-into-his-gig-after-former-employer-discloses-probe/ 2022-05-11T14:30:25+00:00 https://old.journalforclinicalstudies.com/bayers-pharma-business-feels-the-pain-from-xarelto-generics-in-china/ 2022-05-11T14:25:32+00:00 https://old.journalforclinicalstudies.com/pfizer-buys-migraine-partner-biohaven-for-11-6b-betting-on-cgrp-drugs-in-grand-return-to-neuroscience/ 2022-05-11T14:24:09+00:00 https://old.journalforclinicalstudies.com/emergent-destroyed-up-to-400m-covid-19-vaccines-far-more-than-previously-known-report/ 2022-05-11T14:19:54+00:00 https://old.journalforclinicalstudies.com/bristol-myers-squibb-goes-all-out-on-unbranded-campaigns-for-newly-approved-13b-drug-camzyos/ 2022-05-11T14:15:16+00:00 https://old.journalforclinicalstudies.com/fda-converts-emergency-nod-for-lillys-olumiant-to-a-full-approval-for-hospitalized-covid-patients/ 2022-05-11T14:12:56+00:00 https://old.journalforclinicalstudies.com/incyte-says-it-has-added-2nd-manufacturing-site-to-remedy-opzelura-production-problems/ 2022-05-04T08:44:15+00:00 https://old.journalforclinicalstudies.com/no-go-for-zosano-as-fda-knockback-triggers-suspension-of-transdermal-migraine-patch-program/ 2022-05-04T08:42:56+00:00 https://old.journalforclinicalstudies.com/bayers-nubeqa-one-step-closer-to-blockbuster-status-thanks-to-fda-priority-review-in-potential-new-use/ 2022-05-04T08:42:01+00:00 https://old.journalforclinicalstudies.com/biogen-sends-ceo-to-the-exit-abandons-aduhelm-sales-team-in-1b-overhaul/ 2022-05-04T08:40:27+00:00 https://old.journalforclinicalstudies.com/pfizer-sticks-to-guns-on-22b-paxlovid-sales-despite-reports-of-lagging-demand/ 2022-05-04T08:38:57+00:00 https://old.journalforclinicalstudies.com/bexson-expands-on-body-ketamine-delivery-work-into-mental-health/ 2022-05-04T08:33:38+00:00 https://old.journalforclinicalstudies.com/cordenpharma-part-of-germanys-mrna-contingency-plan-sold-to-private-equity-outfit-astorg/ 2022-05-04T08:32:48+00:00 https://old.journalforclinicalstudies.com/sgs-wins-five-categories-in-the-2022-cro-leadership-awards/ 2022-05-03T09:21:44+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2022/05/SGS.png https://old.journalforclinicalstudies.com/genentech-makes-strides-toward-2025-di-goal-that-spans-research-in-house-staffing-and-suppliers/ 2022-04-27T12:38:23+00:00 https://old.journalforclinicalstudies.com/gsks-viiv-pfizer-and-roches-genentech-earn-top-ranks-among-patient-advocacy-groups/ 2022-04-27T12:37:05+00:00 https://old.journalforclinicalstudies.com/novartis-confirms-thousands-of-layoffs-loom-as-its-global-reorganization-rolls-ahead/ 2022-04-27T12:35:42+00:00 https://old.journalforclinicalstudies.com/lawmakers-ask-fda-to-lay-out-plans-for-reviewing-covid-vaccines-for-young-children/ 2022-04-27T12:34:10+00:00 https://old.journalforclinicalstudies.com/novartis-hires-seasoned-wall-street-analyst-ronny-gal-as-new-ma-czar/ 2022-04-27T12:32:40+00:00 https://old.journalforclinicalstudies.com/amcor-to-add-more-capabilities-at-packaging-site-in-ireland/ 2022-04-27T12:30:16+00:00 https://old.journalforclinicalstudies.com/cancer-research-uk-reveals-innovation-engine-underpinned-by-400m-portfolio-of-cutting-edge-discovery-science/ 2022-04-27T10:08:06+00:00 https://old.journalforclinicalstudies.com/abzena-nabs-65m-to-bolster-manufacturing-and-research-services-on-both-sides-of-the-pond/ 2022-04-22T11:07:43+00:00 https://old.journalforclinicalstudies.com/salvat-heads-to-regulators-with-phase-3-data-on-ocular-steroid/ 2022-04-22T11:06:47+00:00 https://old.journalforclinicalstudies.com/rls-bags-10m-to-trial-dry-powder-inhaled-cbd-in-anxiety/ 2022-04-22T11:04:43+00:00 https://old.journalforclinicalstudies.com/johnson-johnson-after-weak-quarter-of-vaccine-sales-will-no-longer-include-it-in-guidance/ 2022-04-20T12:30:58+00:00 https://old.journalforclinicalstudies.com/gilead-targets-400-jobs-assembles-cell-therapy-manufacturing-troika-with-fda-nod-for-maryland-site/ 2022-04-20T12:24:12+00:00